Clinical Trials Browser

Temporarily not available × Expanded_access × Clear all

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07319910 2026-01-06

PANOVA-3CA

Temporarily not available

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Temporarily not available

GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

NCT05274204 2023-02-27

Individual Patient Expanded Access to CA102N

Temporarily not available

Gastrointestinal

Colorectal Neoplasms

NCT02011880 2013-12-13

Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer

Temporarily not available

Breast

Breast Neoplasms

NCT01297101 2011-02-16

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Temporarily not available

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

PANOVA-3CA

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Expanded Access of Vigil in Solid Tumors

Individual Patient Expanded Access to CA102N

Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy